Severe acute respiratory syndrome coronavirus (SARS-COV-2), intellectual disabilities, vaccine hesitancy, chromosomal disorder
Clinical Trial, RCT, arbaclofen, autism, AIMS-2
Down syndrome, intellectual disability, multiple morbidity, health conditions, clustering, incidence
Intellectual disabilities, Aggressive Challenging Behaviour, cluster randomised control trial, Psychosocial intervention, Community Care, Complex Interventions
Down syndrome, COVID-19, High income country, low income country, treatment, severity